欧洲 · 宏观、外汇与加密 · Proactive Investors
Prescient Therapeutics opens $7 million share purchase plan to advance PTX-100
Prescient Therapeutics Ltd (ASX:PTX) has opened its share purchase plan (SPP) targeting up to $7 million to help advance its lead cancer therapy PTX-100 through its ongoing Phase…
在 Proactive Investors 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.proactiveinvestors.co.uk)